Novel research on Neuroprotective effect of Bacopa monnieri L. against propionic acid induced investigation on autism in Sprague Dawley rat
Keywords:
Autism Spectrum disorders, Bacopa monnieri, Brahmi, Memory impairment, Neuroinflammation, Dysregulation, ImmunologicAbstract
Autism spectrum disorder (ASD) is characterized by complex behavioral and memory impairments resulting from abnormal brain development. The research objective is to identify the lack of understanding of the etiology of autism. The Ayurvedic system of medicine recognizes Bacopa monnieri for their potential nootropic activity to maximize brain and neuronal processes such as learning and memory. Brahmi, Bacopa monnieri has been demonstrated in Ayurvedic preparation as memory booster medicine. The neuroprotective properties of hydroalcoholic extract of Bacopa monnieri against propionic acid-induced neuroprotective effect in autistic rat models were investigated in the present study. The animal species used in the study are adult Sprague Dawley rats of both sexes were divided into four groups and administered the vehicle/extract for 28 days. Between the 22nd and 28th days of the trial, autism was caused by an intracerebroventricular infusion of propionic acid. Rats were treated to the fundamental methods such as different in vivo behavior and memory evaluation procedures during this infusion period, including the actophotometer test and the Morris water maze test. Animals were euthanized on the 29th day of the investigation to obtain brain material. Extracted brain tissues were used to calculate levels of neuroinflammatory markers (TNF-) and histological examination.
Downloads
References
Kargas, N., Lopez, B., Reddy, V et al. (2015). The Relationship between Auditory Processing and Restricted, Repetitive Behaviors in Adults with Autism Spectrum Disorders. J Autism Dev Disord, 45, 658–668.
Baker-Ericzén, M.J., ElShamy, R., et al. (2021). Current Status of Evidence-Based Practices to Enhance Employment Outcomes for Transition Age Youth and Adults on the Autism Spectrum. Current Psychiatry Reports, 22, 1-0. https://doi.org/10.1007/s11920-022-01327-2
Haapakoski, R., Mathieu, J., et al. (2015). Cumulative meta-analysis of interleukins 6 and 1β, tumor necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain, behavior, and immunity, 49, 206-15. https://doi: 10.1016/j.bbi.2015.06.001.
Rossignol, D.A., Frye, R.E., et al. (2012). A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Molecular psychiatry, 17(4), 389-401.https://doi: 10.1038/mp.2011.165.
Moradi, K., Ashraf-Ganjouei, A et al. (2021). The interplay between gut microbiota and autism spectrum disorders: A focus on immunological pathways. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 106, 110091.https://doi.org/10.1016/j.pnpbp.2020.110091
Liu, F., Li, J., Wu, F., et al. (2019), Altered composition and function of intestinal microbiota in autism spectrum disorders: a systematic review. Translational psychiatry, 9(1), 1-3.https://doi.org/10.1038/s41398-019-0389-6
Ghosh, A., Michalon Aet al. (2013). Drug discovery for autism spectrum disorder: challenges and opportunities. Nature reviews Drug discovery, 12(10), 777-90. https://doi: 10.1038/nrd4102. PMID: 24080699.
Sharma, R., Rahi, S., et al. (2019). Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidence. Toxicology reports, 6, 1164-75.https:// doi: 10.1016/j.toxrep.2019.10.019.
Gupta, R., Mehan, S., et al. (2022). Smo-Shh agonist Purmorphamine prevents neurobehavioral and neurochemical defects in 8-OH-DPAT-induced experimental model of obsessive-compulsive disorder. Brain Sciences, 12(3), 342. https:// doi: 10.3390/brainsci12030342.
Nandy, S., Mukherjee, A., et al. (2020). Bacopa monnieri: The neuroprotective elixir from the East—Phytochemistry, pharmacology, and biotechnological improvement. In Bioactive Natural products in Drug Discovery, 97-126. Springer, Singapore. https:// doi: 10.1007/978-981-15-1394-7_2
Sriranjini, S.J, Sandhya, K., et al. (2015). Ayurveda and botanical drugs for epilepsy: Current evidence and future prospects. Epilepsy & Behavior, 1; 52:290-6. https:// doi: 10.1016/j.yebeh.2015.05.039.
Gohil, K.J., Patel, J.A., et al. (2010). A review on Bacopa monniera: current research and future prospects. International Journal of Green Pharmacy, 4(1). https:// doi: 10.4103/0973-8258.62156
Achliya, G.S, Barabde U, et al. (2004). Effect of Bramhi Ghrita, an polyherbal formulation on learning and memory paradigms in experimental animals. Indian journal of pharmacology, 36(3), 159. https://www.ijp-online.com/text.asp?2004/36/3/159/6870
Devendra, P., Patel, S.S., et al. (2018). Brahmi (Bacopa monnieri) as functional food ingredient in food processing industry. Journal of Pharmacognosy and Phytochemistry, 7(3), 189-94.
Bui, T.T., Nguyen, T.H, et al. (2017). Natural product for the treatment of Alzheimer's disease. Journal of basic and clinical physiology and pharmacology, 28(5), 413-23. https:// doi: 10.1515/jbcpp-2016-0147.
Zhou, H., Xu, X., et al., (2020). Prevalence of autism spectrum disorder in China: a nationwide multi-center population-based study among children aged 6 to 12 years. Neuroscience Bulletin, 961-71. https:// doi: 10.1007/s12264-020-00530-6
Satoh, M., Chan, E.K., et al. (2012). Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis & Rheumatism, 64(7), 2319-27. https:// doi: 10.1002/art.34380.
Anamika, K., Muralidharan, P. (2015). Autistic Effects of Nootropic Drug Brahmi against Propionic Acid-induced Behavior and Memory Impairment in Rat Model. https//doi.org/10.9734/jpri/2021/v33i47A32995
Tamboli FA, Rangari VDet al. (2018). Comparative phytochemical evaluation of natural and micro propagated plants of Bacopa monnieri (L.). Marmara Pharmaceutical Journal, 22(1). https:// doi:10.12991/mpj.2018.42
Moriasi, G.A, Ireri, A.M, et al., (2020). In vivo cognitive-enhancing, Ex vivo malondialdehyde-lowering activities and phytochemical profiles of aqueous and methanolic stem bark extracts of Piliostigma thonningii (Schum.). International Journal of Alzheimer's disease. https:// doi: 10.1155/2020/1367075
Morris, R.G., et al., (1989). Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. Journal of Neuroscience, 9(9), 3040-57. https:// doi:10.1523/JNEUROSCI.09-09-03040.1989.
Susilo, C. B., Jayanto, I., & Kusumawaty, I. (2021). Understanding digital technology trends in healthcare and preventive strategy. International Journal of Health & Medical Sciences, 4(3), 347-354. https://doi.org/10.31295/ijhms.v4n3.1769
Matovu, D., Alele, P.E., et al., (2018). Seizure vulnerability and anxiety responses following chronic co-administration and acute withdrawal of caffeine and ethanol in a rat model. Journal of Basic and Clinical Physiology and Pharmacology, 29(1), 1-0.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949
Pahle ,J., et al., (1758). The effects of cell-specific Reelin depletion in inhibitory interneurons on the dentate gyrus of adult mice (Mus musculus, Linnaeus 1758) (Doctoral dissertation, Staats-und Universitätsbibliothek Hamburg Carl von Ossietzky.
Thorpe, C.M., Bates, M.E, et al., (2003). Rats have trouble associating all three parts of the time–place–event memory code. Behavioural Processes, 63(2), 95-110
Thomas, R.H., Foley, K.A., et al., (2010). Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders. Journal of neurochemistry, 113(2), 515-29.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.